Add-on Medication Improves Heart Attack Prognosis

Patients who receive add-on cholesterol-lowering medication, ezetimibe, soon after a heart attack have a significantly better prognosis than those who receive the drug later or not at all. The corresponding study was published in the Journal of the American College of Cardiology. 

Current treatment guidelines for patients immediately following a heart attack include high-potency statins to lower cholesterol levels and stabilize changes in blood vessels…